PetMed Express appoints CFO Bruce Rosenbloom as interim CEO following Menderes Akdag's departure

PETMED EXPRESS INC

CEO Menderes Akdag's employment contract ends July 30, 2021; Board decided not to extend.
CFO Bruce Rosenbloom appointed Interim CEO and President effective July 31, 2021; he remains CFO.
Rosenbloom receives additional $10,000/month cash stipend for interim CEO duties.
Board expects to appoint permanent CEO within ~3 months (by Oct 31, 2021).
No new severance arrangement; Rosenbloom's existing change-of-control severance unchanged.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Bruce S. Rosenbloom

Interim Chief Executive Officer and President

PETS · PETMED EXPRESS INC

Effective: 2021-07-31
Filed: July 6, 2021, 7:59 PM ET

the Board appointed Bruce S. Rosenbloom, the Company’s Chief Financial Officer, as Interim Chief Executive Officer (principal executive officer) and President of the Company, effective upon Mr. Akdag’s departure

Departed

Menderes Akdag

President and Chief Executive Officer

PETS · PETMED EXPRESS INC

Effective: 2021-07-30
Successor: Bruce S. Rosenbloom
Filed: July 6, 2021, 7:59 PM ET

the Company will not extend Mr. Akdag’s employment agreement with the Company and that the employment agreement would therefore end on July 30, 2021

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Bruce S. Rosenbloom was appointed as Interim Chief Executive Officer and President at PETMED EXPRESS INC.

Action: appointed
Role: Interim Chief Executive Officer and President

Exact text from the filing

the Board appointed Bruce S. Rosenbloom, the Company’s Chief Financial Officer, as Interim Chief Executive Officer (principal executive officer) and President of the Company, effective upon Mr. Akdag’s departure

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Menderes Akdag departed as President and Chief Executive Officer at PETMED EXPRESS INC.

Action: not extended
Role: President and Chief Executive Officer

Exact text from the filing

the Company will not extend Mr. Akdag’s employment agreement with the Company and that the employment agreement would therefore end on July 30, 2021

View on SEC.gov

PETMED EXPRESS INC filing history →

Source: SEC EDGAR

accession 0001437749-21-016414

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.